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Background: The use of mesenchymal stem cells (MSCs) and coralline hydroxyapatite (HA) or biphasic calcium
phosphate (BCP) as a bone substitute for posterolateral spinal fusion has been reported. However, the genes and
molecular signals by which MSCs interact with their surrounding environment require further elucidation.
Methods: MSCs were harvested from bone grafting patients and identified by flow cytometry. A composite scaffold
was developed using poly(lactide-co-glycolide) (PLGA) copolymer, coralline HA, BCP, and collagen as a carrier matrix
for MSCs. The gene expression profiles of MSCs cultured in the scaffolds were measured by microarrays. The
alkaline phosphatase (ALP) activity of the MSCs was assessed, and the expression of osteogenic genes and proteins
was determined by quantitative polymerase chain reaction (Q-PCR) and Western blotting. Furthermore, we cultured
rabbit MSCs in BCP or coralline HA hybrid scaffolds and transplanted these mixtures into rabbits for spinal fusion.
We investigated the differences between BCP and coralline HA hybrid scaffolds by dual-energy X-ray
absorptiometry (DEXA) and computed tomography (CT).
Results: Tested in vitro, the cells were negative for hematopoietic cell markers and positive for MSC markers. There
was higher expression of 80 genes and lower of 101 genes of MSCs cultured in BCP hybrid scaffolds. Some of these
genes have been shown to play a role in osteogenesis of MSCs. In addition, MSCs cultured in BCP hybrid scaffolds
produced more messenger RNA (mRNA) for osteopontin, osteocalcin, Runx2, and leptin receptor (leptin-R) than
those cultured in coralline HA hybrid scaffolds. Western blotting showed more Runx2 and leptin-R protein
expression in BCP hybrid scaffolds. For in vivo results, 3D reconstructed CT images showed continuous bone
bridges and fusion mass incorporated with the transverse processes. Bone mineral content (BMC) values were
higher in the BCP hybrid scaffold group than in the coralline HA hybrid scaffold group.
Conclusions: The BCP hybrid scaffold for osteogenesis of MSCs is better than the coralline HA hybrid scaffold by
upregulating expression of leptin-R. This was consistent with in vivo data, which indicated that BCP hybrid scaffolds
induced more bone formation in a spinal fusion model.
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Autogenous bone is the most effective graft material
for the repair of bone defects or for spinal fusion; how-
ever, donor site morbidity is a major limitation on its
clinical use [1]. To avoid this limitation, one tissue en-
gineering approach would be to combine cells capable
of osteogenic activity with an appropriate scaffolding
material to stimulate bone regeneration and repair.
The use of calcium phosphate ceramics as substitutes
for bone grafts is steadily increasing due to ongoing
improvement of the materials. The most widely used
calcium phosphate ceramics are porous hydroxyapatite
(HA), phosphate (β-TCP), and mixtures of these two
that are known as biphasic calcium phosphate (BCP)
ceramics [2–4].
Mesenchymal stem cells (MSCs) have the potential to
differentiate into lineages of various mesenchymal
tissues, including bone, cartilage, fat, tendon, and
muscle. Many surface antigens are often expressed on
human MSCs, such as CD146, CD106, CD105, CD90,
Stro-1, and α-SMA [5, 6]. MSCs have great appeal for
tissue engineering and therapeutic applications. MSCs
combined with HA [7] or BCP [8] ceramics have been
shown to induce bone formation. In addition, the use of
MSCs on HA [9] or BCP [10] as a bone substitute for
posterolateral spinal fusion also has been reported.
However, the molecular and biochemical signals by
which MSCs interact with their surrounding environ-
ment require further elucidation to develop improved
scaffolding materials.
In the process of biological developmental, osteoblasts
differentiate from mesenchymal progenitors, going
through distinct developmental stages that are regulated
by various developmental signals and signaling pathways.
These pathways include BMP signaling [11], Hedgehog
signaling [12], Notch signaling [13], Wnt signaling [14],
FGF signaling [15], and leptin–leptin-R signaling [16].
Leptin is a 16-kDa peptide hormone product of the ob
(Lep) gene that is secreted by white adipose tissue [17],
human osteoblasts [18], and MSCs [19]. Leptin-R is
expressed on the surface of human bone marrow MSCs
[20]. Leptin has a significant effect of promoting osteo-
genesis and inhibiting adipogenesis in MSCs. Runx2
messenger RNA (mRNA) expression is upregulated by
leptin during osteogenesis in MSCs, while leptin reduced
PPARγ2 mRNA expression during adipogenesis in MSCs
[21, 22]. Combined treatment with leptin and rhBMP-2
has a synergistic osteoinductive activity in nude mice
[23]. In addition, leptin inhibits osteoclast generation
[24]. Leptin increased osteoprotegerin (OPG) mRNA
and protein expression in MSCs, and the inhibitory
effect may be mediated by the RANKL/RANK/OPG
system [24]. Leptin activity in MSCs from osteoporotic
women appears hampered, suggesting that inadequateleptin activity contributes to excessive lipid accumula-
tion in the bone marrow [21, 22].
Previous studies have employed various molecular
methods to analyze gene expression in cells and tissues in
contact with biomaterials and their dissolution products
[25, 26]. In the present study, we used alkaline phosphat-
ase (ALP) activity, quantitative polymerase chain reaction
(Q-PCR), and Western blotting to analyze gene and
protein expression during osteogenesis of MSCs cultured
in different combinations of osteoconductive materials
(HA, BCP, and collagen). By comparing the expression
profile of leptin, leptin-R, ALP, osteopontin (OPN), osteo-
calcin (OSC), and Runx2, we first proved that calcium
phosphate ceramics could stimulate the differentiation of
MSCs via influencing the expression of molecules in the
leptin/leptin-R/ALP/OSC signaling pathway. In addition,
we cultured rabbit MSCs in BCP or HA hybrid scaffolds
and transplanted these mixtures into rabbits for posterior
spinal fusion. We investigated the differences between
BCP and HA hybrid scaffolds by dual-energy X-ray
absorptiometry (DEXA) and computed tomography (CT)
examination.
Materials and methods
The experimental protocol was approved by the human
subjects Institutional Review Board and the Institutional
Animal Care and Use Committee of the Chang Gung
Memorial Hospital.
Surgical procedures
MSCs were harvested from patients who underwent iliac
bone grafting for spine fusion. For each patient, 10 mL
of bone marrow was aspirated and collected in a sterile
heparin-rinsed syringe.
Isolation and cultivation of MSCs
Each marrow sample was washed with phosphate-
buffered saline (PBS). Up to 2 × 108 nucleated cells in
5 mL of PBS were loaded onto 25 mL of Percoll cushion
(Pharmacia Biotech). A density gradient was used as the
isolation procedure to eliminate unwanted cell types. A
small percentage of cells were isolated from the density
interface at 1.073 g/mL. The cells were resuspended and
plated in T-75 flasks at 2 × 105 cells per flask. The cells
were maintained in Dulbecco’s Modified Eagle’s Medium-
Low Glucose (DMEM-LG; Gibco, Grand Island, NY) con-
taining 20 % fetal bovine serum (FBS) and antibiotics at
37 °C in a humidified atmosphere of 5 % CO2 and 95 %
air. After 7 days of primary culturing, the non-adherent
cells were removed by changing the medium. The MSCs
grew as symmetric colonies and were subcultured at 10 to
14 days by treatment with 0.05 % trypsin (Gibco) and
seeded into fresh flasks.
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When confluent, the MSCs were passaged 1 in 3, and a
sample was analyzed by flow cytometry for MSC marker
expression. The cells were washed in PBS and then re-
moved from the flask by 0.05 % trypsin (Gibco). 1 × 105
cells were incubated with each mouse monoclonal primary
antibody at 4 °C for 30 min. Mouse FITC-conjugated anti-
CD105 antibody (1:100 dilution) and mouse FITC-
conjugated anti-CD34 antibody (1:100 dilution) were
purchased from Becton Dickinson (Oxford, UK). Mouse
FITC-conjugated anti-αSMA antibody (1:25 dilution) was
purchased from Abcam (Cambridge, UK). Mouse PE-
conjugated anti-STRO-1 antibody (1:50 dilution) was pur-
chased from Santa Cruz (CA, USA). After wash, the cells
were resuspended in 500 μL wash buffer and analyzed on
a BD flow cytometer (Oxford, UK).
Construction of the PLGA–calcium phosphate–collagen
carrier for MSCs
A composite system was developed using poly(lactide-co-
glycolide) (PLGA) copolymer, coralline HA, BCP ceramics,
and collagen as a carrier matrix for MSCs. PLGA (300 mg;
Boehringer Ingelheim, Germany) and coralline HA ceram-
ics (100 mg; Pro-Osteon 500R, Interpore International,
Irvine, CA) or BCP (15 % HA/85 % β-TCP 100 mg;
MASTERGRAFT® Granules, BioHorizons IPH Inc., USA)
were loaded into molds and hot compression molded at
55 °C to form a PLGA/coralline HA or PLGA/BCP
capsule graft. Roughly, 107 MSCs were mixed well with
0.8 mL of type I collagen solution (Roche, Germany),
0.1 mL of 0.2 mol/L HEPES (pH 7.3), and 0.1 mL of
10× concentrated complete medium (DMEM-LG) or
osteogenic medium (DMEM-LG containing 100 mmol/L
ascorbate-2 phosphate, 10−7 M dexamethasone, 10 mmol/L
β-glycerophosphate, and 20 % FBS) and stored at 4 °C. Ap-
proximately 250 μL of the MSC–collagen mixture was
loaded into the cores of a PLGA/coralline HA or PLGA/
BCP capsule and incubated at 37 °C for 8 h to enable colla-
gen gel formation. The composite systems were cultured in
six-well plates containing 2.5 mL of complete medium or
osteogenic medium and incubated at 37 °C. The medium
was changed per 72 h.
Quantitative measurement of ALP activity
After culturing for 14 days, the culture medium was
withdrawn and the MSC carrier was washed twice with
5 mL of Tyrode’s balanced salt solution. A 5-mL aliquot
of ALP substrate buffer (50 mmol/L glycine, 1 mmol/L
MgCl2, pH 10.5), containing the soluble chromogenic
ALP substrate (2.5 mmol/L p-nitrophenyl phosphate),
was added at room temperature. During incubation,
ALP converts p-nitrophenyl phosphate into p-nitrophenol,
which is yellow in color. Twenty minutes after substrate
addition, 1 mL of the buffer was withdrawn and mixedwith 1 mL of 1 N NaOH to stop the reaction. The absorb-
ance of the mixture was read in triplicate at 405 nm on an
ELISA MRX plate reader (Dynatech Labs, Chantilly, VA).
Enzyme activity was expressed as nanomoles p-nitrophenol
per minute per dish.
RNA preparation and Q-PCR analysis
After culturing for 7 or 14 days, total RNA was ex-
tracted using a Qiagen RT kit (Qiagen, USA) according
to the manufacturer’s instructions. The RNA concen-
tration was evaluated by A260/A280 measurement. To
detect leptin-R, OPN, OSC, Runx2, and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) RNA transcripts,
cDNA was analyzed on an ABI PRISM 7900 sequence
detection system using TaqMan PCR Master Mix
(Applied Biosystems, Foster City, CA). The cycle
threshold (Ct) values were obtained, and the data were
normalized to GAPDH expression by using the ΔΔCt
method to calculate the relative mRNA level of each
gene.
Western blot analysis
After culturing for 7 or 14 days, the cells were washed
with PBS and extracted using M-PER protein extraction
reagent (Thermo, USA). The protein content was quanti-
tated using a protein assay kit (Pierce Biotechnology, IL),
separated by 7.5 % SDS-PAGE, and transferred onto
membranes using a transfer unit (Bio-Rad, USA). After
blocking, the membranes were incubated with 1000-fold
diluted rabbit antibodies against leptin (R&D, MN, USA),
leptin-R (R&D), Runx2 (Millipore, Temecula, CA), and
β-actin (Millipore). After washing, the membranes were
further incubated for 2 h with 10,000-fold goat anti-
mouse IgG (Calbiochem, USA) or goat anti-rabbit IgG
(Millipore) conjugated to horseradish peroxidase. The
membranes were then washed and rinsed with ECL detec-
tion reagents (Millipore). The bands were photographed
using ECL Hyperfilm (Amersham Pharmacia Biotech,
UK), and their intensity was quantified using an image
analysis system (Image-Pro plus 5.0).
Microarray analysis
After culturing, cells were collected for studying the
differential gene expression pattern using Affymetrix
Human Genome U133 plus microarrays (Affymetrix,
Santa Clara, CA) according to the manufacturer’s proto-
col. RNA preparation was performed using Qiagen’s
RNeasy Mini Kit, and the integrity and purity were ana-
lyzed using Agilent Bioanalyzer and NanoDrop spectro-
photometer. Raw gene expression data were normalized
and analyzed with GeneChip Operating Software 1.4
(GCOS, Affymetrix). Genes that are >1.5-fold up- or
downregulated between two groups were selected.
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Six New Zealand white rabbits, each about 8 months old
and weighing 3.3 to 3.8 kg, were used. Under anesthesia,
a 6-cm dorsal midline incision was made to expose the
bilateral paramedian fascia. The intermuscular plane be-
tween the multifidus and longissimus muscles was dis-
sected to expose the intertransverse space between L4
and L5. The soft tissues between the L4 and L5 trans-
verse processes were dissected, and decortication of the
transverse processes was performed by using an electric
burr. An MSC/PLGA/BCP/collagen graft was placed on
the left side and a MSC/PLGA/coralline HA/collagen
graft was placed on the right side between the transverse
processes in the paraspinal bed. The fascia and skin inci-
sions were sutured. The rabbits were killed at 10 weeks
after grafting and underwent radiographic, CT, and bone
mineral content (BMC) examinations.Computed tomography examination
At 10 weeks after grafting, three rabbits underwent
high-resolution helical CT scanning at a 2.0-mm slice
resolution in 1.0-mm increments. CT images were trans-
ferred to a workstation and reconstructed three-
dimensionally. Multiple slices obtained in three planes
were reviewed for each fusion mass.Dual-energy X-ray absorptiometry examination
At 10 weeks after grafting, three rabbits underwent
BMC measurements by using a Hologic QDR 2000 dual-
energy X-ray absorptiometry system (Hologic, Inc.,
Boston, MA). A self-contained X-ray source was mounted
beneath an animal to provide alternating pulses at 70 and
140 kVp. An X-ray detector was then mounted above the
animal, and both source and detector were moved across
the animal under computer control in a serpentine pattern.
The two radiation energies were generated as collimated
beams and their absorption patterns allowed for the meas-
urement of BMC in grams.Results
In vitro studies
Flow cytometry analysis
Primary adherent human MSCs from three donors were
cultured in a control medium, and the cells were ana-
lyzed for expression of MSC markers using flow cytome-
try at passage 1. The percentage of cells expressing the
MSC markers CD105, Stro-1, and α-SMA and the
hematopoietic stem cell (HSC) marker CD34 are shown
in Fig. 1. The mean percentages of CD105+, Stro-1+,
α-SMA+, and CD34+ cells in the cell preparations
from three patients were calculated to be 85.7 ± 5.7,
32.7 ± 4.9, 53.6 ± 1.8, and 0.21 ± 0.07 %, respectively.Gene expression profiling
MSCs cultured in different scaffolds modulate the ex-
pression of several genes, leading to higher expression of
80 genes (BCP hybrid scaffold/coralline HA hybrid
scaffold ratio >1.5-fold) and lower expression of 101
genes (BCP hybrid scaffold/coralline HA hybrid scaffold
ratio <0.67-fold) in BCP hybrid scaffolds in 22,215 hu-
man genes. The top 12 higher and lower gene expres-
sions of MSCs cultured in BCP hybrid scaffolds are
shown in Table 1.
mRNA expression of osteogenic genes and leptin-R
Figure 2 presents the mRNA expression of osteogenic
genes and leptin-R in the MSCs. After 7 days of culture, the
mRNA levels of leptin-R (1.44 ± 0.23-fold, *p < 0.05, n = 3),
osteopontin (1.65 ± 0.38-fold, *p < 0.05, n = 3), and Runx2
(1.43 ± 0.2-fold, *p < 0.05, n = 3) were significantly higher
in the PLGA/BCP-group MSCs than in the PLGA/
coralline-HA-group MSCs. After 14 days of culture, the
mRNA levels of leptin-R (2.27 ± 0.36-fold, **p < 0.01,
n = 3), osteopontin (3.18 ± 0.55-fold, **p < 0.01, n = 3),
osteocalcin (1.83 ± 0.34-fold, *p < 0.05, n = 3), and Runx2
(2.28 ± 0.29-fold, **p < 0.01, n = 3) were significantly
higher in the PLGA/BCP-group MSCs than in the PLGA/
coralline-HA-group MSCs.
Osteogenic protein expression
Figure 3 presents the Western blotting results for the ex-
pression of osteogenic proteins in the MSCs. Compared
to a control group, the expression of the detected osteo-
genic protein in the coralline-HA-group MSCs and in
the BCP-group MSCs was considerably enhanced. After
14 days of culture, the protein levels of leptin-R (BC14/
BO14 0.12 ± 0.03-fold, **p < 0.01, n = 3), leptin (BC14/
BO14 0.70 ± 0.06-fold, *p < 0.05, n = 3), and Runx2
(BC14/BO14 0.65 ± 0.07-fold, *p < 0.05, n = 3) were sig-
nificantly higher in the BCP/osteogenic-group MSCs
than in the BCP/control-group MSCs. Additionally, the
protein levels of leptin-R (HO14/BO14 0.24 ± 0.04-fold,
**p < 0.01, n = 3) and Runx2 (HO14/BO14 0.61 ± 0.04-
fold, **p < 0.01, n = 3) were significantly higher in the
BCP/osteogenic-group MSCs than in the coralline-HA/
osteogenic-group MSCs.
Quantitative measurement of ALP
Figure 4 presents the results of ALP activity measure-
ments. MSCs cultured in a PLGA/coralline HA hybrid
scaffold or PLGA/BCP hybrid scaffold had significantly
lower ALP activity levels in the control (complete)
medium than in the osteogenic medium throughout the
14-day culture period. In addition, ALP activity levels in
the PLGA/BCP-group MSCs cultured in osteogenic
medium were significantly higher than those in the
PLGA/coralline-HA-group MSCs throughout the 14-day
Fig. 1 Flow cytometry analysis. The mean percentages of CD105+, Stro-1+, α-SMA+, and CD34+ cells were calculated to be 85.7 ± 5.7, 32.7 ± 4.9,
53.6 ± 1.8, and 0.21 ± 0.07 %, respectively
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1.57 ± 0.21 vs. 2.53 ± 0.4, p < 0.05, n = 3).
In vivo studies
Computed tomography findings
3D CT reconstructions revealed the presence of con-
tinuous bone bridges and satisfactory fusion mass incor-
porated with the transverse processes (Fig. 5a, b).
Dual-energy X-ray absorptiometry examination
Radiographs of the specimens retrieved from the BCP
graft and coralline HA graft showed continuous trabecu-
lar bone patterns in the area between the transverse pro-
cesses (Fig. 6a). The BMC values were higher in the BCP
graft than in the coralline HA graft (Fig. 6b; BCP vs. cor-
alline HA 0.36 ± 0.05 vs. 0.26 ± 0.03 g, *p < 0.05, n = 3).
Discussion
A recent study proposed the theory that certain mate-
rials could trigger the secretion of factors leading to
bone formation rather than simply causing the accumu-
lation of such factors [27]. Other studies have focusedon the direct effects of different materials on various
types of multipotential cells that can eventually differen-
tiate into osteocytes, such as adipose-derived stem cells
[28], C2C12 cells [29], and bone marrow MSCs [30].
The MSCs used here were characterized by the presence
of a consistent set of marker proteins on their surface.
The percentages of cells expressing the human MSC
markers CD105, Stro-1, and α-SMA are shown in Fig. 1.
Up to now, a series of biomaterials have been reported
to be osteoinductive, including demineralized bone
matrix [16], porous HA ceramics [31], and TCP ceramics
[3]. Although these findings expanded the understanding
of osteoinductive biomaterials, the osteoinductive mech-
anism of those biomaterials behind the phenomenon of
ectopic formation is still not fully understood. Tan et al.
observed that HA and BCP induced the expression of
osteogenic markers in C2C12 cells, but they did not
quantify the differences between the two ceramics [29].
Barradas et al. showed that MSCs cultured in β-TCP ex-
press more OPN, OC, collagen type I (Col I), and bone
sialoprotein (BSP) than MSCs cultured in HA after 7 days
[32]. In the present study, coralline HA hybrid scaffold
Table 1 Microarray analyses of the top 12 higher and lower
gene expressions of MSCs cultured in BCP hybrid scaffolds










MAFB 9935 NM_005461 2.99
IFI16 3428 NM_005531 2.81
FLJ10159 55084 NM_018013 2.35
MMP13 4322 NM_002427 2.27
COL21A1 81578 NM_030820 2.09
EIF4A1 1973 NM_001416 2.02
SEPP1 6414 NM_005410 1.95
APOE 348 NM_000041 1.94




PTGFR 5737 NM_000959 1.93
OLFML2B 25903 NM_015441 1.89
(b) Lower
INHBA 3624 NM_002192 0.50




GOLGA8A 23015 NM_015003 0.48
STMN2 11075 NM_007029 0.48
RIS1 25907 NM_015444 0.48
PPAP2B 8613 NM_003713 ///
NM_177414
0.47
PWP1 11137 NM_007062 0.46
IQGAP1 8826 NM_003870 0.43
COMP 1311 NM_000095 0.41
RGC32 28984 NM_014059 0.38
STC1 6781 NM_003155 0.36
PGK1 5230 NM_000291 0.33
Fig. 2 mRNA expression of osteogenic genes and leptin-R. After
7 days of culture, the mRNA levels of leptin-R (*p < 0.05, n = 3),
osteopontin (*p < 0.05, n = 3), and Runx2 (*p < 0.05, n = 3) were
significantly higher in the PLGA/BCP-group MSCs than in the PLGA/
coralline-derived-HA-group MSCs. After 14 days of culture, the mRNA
levels of leptin-R (**p < 0.01, n = 3), osteopontin (**p < 0.01, n = 3),
osteocalcin (*p < 0.05, n = 3), and Runx2 (**p < 0.01, n = 3) were
significantly higher in the PLGA/BCP-group MSCs than in the
PLGA/coralline-derived-HA-group MSCs
Fig. 3 Osteogenic protein expression. Compared to a control
group, the expression of the detected osteogenic proteins in the
coralline-derived-HA-group MSCs and in the BCP-group MSCs was
considerably enhanced. After 14 days of culture, the protein levels
of leptin-R (**p < 0.01, n = 3), leptin (0.70 ± 0.06-fold, *p < 0.05,
n = 3), and Runx2 (*p < 0.05, n = 3) were significantly higher in the
BCP/osteogenic-group MSCs than in the BCP/control-group MSCs.
Additionally, the protein levels of leptin-R (**p < 0.01, n = 3) and Runx2
(**p < 0.01, n = 3) were significantly higher in the BCP/osteogenic-group
MSCs than in the coralline-derived-HA/osteogenic-group MSCs
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the protein expression of osteogenic markers of MSCs in
the osteogenic medium (Fig. 3). In addition, we found
higher mRNA expression of OPN, Runx2, and OSC
(Fig. 2); higher protein levels of leptin, leptin-R, and
Runx2 (Fig. 3); and higher ALP activity (Fig. 4) in MSCs
grown in the PLGA/BCP hybrid scaffold which were cul-
tured in the osteogenic medium. All of the above findings
make it more reasonable to conclude that the osteoin-
ductive feature of these materials might rely on their abil-
ity to directly induce the differentiation of MSCs along
an osteoblastic lineage.Several signaling pathways and molecules have been
shown to be critical for MSC differentiation along an
osteogenic lineage [33, 34]. To explore the critical mole-
cules initiating the osteoblastic differentiation of cells
stimulated by calcium phosphate materials, Tang et al.
Fig. 4 Quantitative measurement of ALP. MSCs cultured in PLGA/
coralline-derived HA hybrid scaffolds or PLGA/BCP hybrid scaffolds
had significantly lower ALP activity levels in the control (complete)
medium than in the osteogenic medium throughout the 14-day
culture period. In addition, ALP activity levels in the PLGA/BCP-group
MSCs cultured in the osteogenic medium were significantly higher
than those in the PLGA/coralline-derived-HA-group MSCs throughout
the 14-day culture period (*p < 0.05, n = 3)
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HA and BCP, could upregulate the gene expression of
BMPs, in addition to even upregulating the expression
of intracellular signal transduction molecules in the
Smad pathway during osteogenesis in MSCs [35]. Leptin
exerts its effect by binding to leptin-R and activating the
JAK/STAT pathway, which is highly expressed in human
osteoblasts [36, 37]. In the present study, the BCP hybrid
scaffold culture resulted in higher upregulation of
mRNA (Fig. 2) and protein (Fig. 3) expression of leptin-
R in MSCs than did the coralline HA hybrid scaffold.
Leptin [19] and leptin-R [20] are expressed in MSCs and
might act as a local (autocrine) factor in the osteogenesis
of MSCs and bone remodeling. Enhancement of the ex-
pression of transforming growth factor (TGF)-β [38] and
ALP [39] by leptin has previously been reported, and the
stimulatory effect of leptin on the osteogenesis of MSCs
was also confirmed by the ALP activity measured in this
study (Fig. 4).
Resorbable devices have been used in applications
such as fracture fixation, bone grafting, spinal fusion,
and deformity correction. A previous study showed the
HA-grafted implants were poorly anchored compared
with allografted implants, suggesting that coralline HA
granules should be considered a bone graft extender ra-
ther than a bone graft substitute [40]. Coralline-derived
HA typically performs in an inferior manner to other
HA materials in implant fixation. However, coralline-
derived HA representing as a promising bone graft ex-
tender in spinal fusion has also been reported [41]. In
addition, a system review showed the overall fusion ratefor all ceramic products (including β-TCP, BCP, calcium
sulfate, coralline hydroxyapatite, synthetic hydroxyapatite,
silicated hydroxyapatite) as a bone graft extender in the
lumbar spine was 86.4 % in 30 studies with 1332 patients.
The data for coralline hydroxyapatite (Pro-Osteon 200,
Pro-Osteon 500) was 86.9 % in 7 studies with 168 pa-
tients. The coralline-derived HA typically performs in a
similar manner to other HA materials in the lumbar
spinal fusion [42]. In our previous study, we showed
that the MSC/coralline-derived HA/type I collagen hy-
brid graft could be effectively used to achieve postero-
lateral spinal fusion [9]. In this study, we further
investigated the gene, mRNA, and protein expression of
MSCs cultured on BCP hybrid scaffolds and coralline-
derived HA hybrid scaffolds (Figs. 2, 3, and 4). In
addition, we put these MSC–BCP hybrid scaffolds and
MSC–coralline-derived HA hybrid scaffolds into rab-
bits for spinal fusion test (Figs. 5 and 6).
Previous studies demonstrated that HA/TCP stimu-
lated the osteogenic differentiation of MSCs [43, 44]. In
this study, BCP hybrid scaffolds were performed using
MASTERGRAFT, a commercial composite consisting of
15 % HA and 85 % β-TCP. HA is a material with bio-
mechanical properties similar to natural bone. Briefly,
when compared to β-TCP, HA is a more stable phase
under physiological conditions, as it has a lower solubil-
ity and, thus, slower resorption kinetics [45, 46]. There-
fore, the BCP concept is determined by the optimum
balance of a more stable phase of HA and a more sol-
uble TCP. Due to a higher biodegradability of the β-TCP
component, the reactivity of BCP increases with the
TCP/HA ratio increasing.
Differences in the porosity and surface area of particles
within the material can influence its performance char-
acteristics. Porosity is defined as a percentage of voids in
solids and this morphological property is independent of
the material. The surface area of porous bodies is much
higher, which guarantees a good mechanical fixation in
addition to providing sites on the surface that allow
chemical bonding between the bioceramics and bones
[47]. In addition, pore dimensions are also important.
The dimensions of open pores are directly related to
bone formation, since such pores grant both the surface
and space for cell adhesion and bone ingrowth [48]. In
this study, coralline-derived HA hybrid scaffolds were per-
formed using the commercial product Pro-Osteon 500.
Pro-Osteon 500 is prepared by the hydrothermal conver-
sion (260 °C, 15,000 psi) of coral (consisting of mostly
CaCO3, calcite form) in the presence of ammonium phos-
phate to hydroxyapatite [49]. Pro-Osteon 500 has a poros-
ity rate of 60–70 % and a mean pore size of 500 μm. BCP
hybrid scaffolds were performed using MASTERGRAFT.
BCP of varying HA to β-TCP weight ratios is ob-
tained by sintering precipitated calcium-deficient
Fig. 5 Computed tomography findings. Three-dimensional CT reconstructions revealed the presence of continuous bone bridges and satisfactory
fusion mass incorporated with the transverse processes (a, b)
Niu et al. Journal of Orthopaedic Surgery and Research  (2015) 10:111 Page 8 of 10apatite (Ca/P molar ratio <1.67). MASTERGRAFT has
a porosity rate of 80 % and a mean pore size of
500 μm. The mean pore size between the two cal-
cium phosphate materials is equal, but the porosity
rate is higher in MASTERGRAFT than in Pro-Osteon
500. This may be one of the reasons why the BMC
values were higher in BCP hybrid scaffolds than in
coralline-HA hybrid scaffolds (Fig. 6).Fig. 6 Dual-energy X-ray absorptiometry examination. Radiographs of th
continuous trabecular bone patterns in the area between the transvers
in the coralline-derived HA graft (b; *p < 0.05, n = 3)To analyze the osteoinductive potential of ceramics
in vivo, a previous study conducted ectopic implantation
in the muscle tissue and femoral cortical bones of dogs
[50]. In muscle, histomorphometric analysis showed
earlier and more bone formed in BCP than in HA. In
femoral cortical bone defects, significantly more bone
was formed in BCP than in HA. Similarly, a comparison
between HA and BCP sintered at the same temperaturee specimens retrieved from the BCP graft and HA graft showed
e processes (a). The BMC values were higher in the BCP graft than
Niu et al. Journal of Orthopaedic Surgery and Research  (2015) 10:111 Page 9 of 10(thus with similar macro- and microstructural features
but different chemistry) showed a more pronounced
bone formation in BCP [51]. Our previous study showed
that an MSC/coralline HA/type I collagen hybrid graft
could be effectively used to achieve posterolateral spinal
fusion in a rabbit model [9]. In the present study, we
used the clinically relevant posterolateral spinal fusion
model in which two materials can be compared in a
paired manner. In our results, 3D reconstructed CT im-
ages showed continuous bone bridges and fusion mass
incorporated with the transverse processes (Fig. 5). BMC
values were higher in BCP hybrid scaffolds than in coral-
line HA hybrid scaffolds (Fig. 6). These results indicated
that the osteogenic capacities of osteoinductive materials
in osseous fusion sites are correlated: the higher the
osteoinductive potential of the material, the faster the
formation of the bone bridges.
To provide more information, we show the microarray
analysis of MSCs cultured on coralline-derived HA hy-
brid scaffolds and BCP hybrid scaffolds in Table 1.
Higher levels of osteogenic marker expression in BCP
hybrid scaffolds were shown (Runx2 and leptin-R). In
addition, higher levels of MAFB and IQGAP1 and lower
levels of COMP expression in BCP hybrid scaffolds were
shown. MAFB (v-maf musculoaponeurotic fibrosarcoma
oncogene homolog B) is a biomarker for rheumatoid
arthritis [52]. IQGAP1 (IQ motif containing GTPase acti-
vating protein 1) modulates many different signaling path-
ways and cellular functions, including mitogen-activated
protein kinase (MAPK) signaling, Ca2+/calmodulin signal-
ing, cell–cell adhesion, β-catenin-mediated transcription,
and microbial invasion [53]. COMP (cartilage oligomeric
matrix protein) is a biomarker for cartilage degradation
[54]. However, the role of MAFB, IQGAP1, and COMP in
osteogenesis of MSCs needs to be further investigated.
In conclusion, the results of the present study indicate
that a BCP culture is more effective than an HA culture
at inducing the osteogenesis of MSCs due to the greater
capacity of the BCP culture to upregulate the expression
of leptin receptors and even the intracellular signal
transduction molecules of osteogenesis of MSCs. This is
correlated to in vivo data, where BCP induced more
bone formation in a rabbit spinal fusion model.
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